TargetMol

RWJ 676070

Product Code:
 
TAR-T28629
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T28629-5mg5mg£1,251.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28629-50mg50mg£2,464.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28629-100mg100mg£3,283.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
RWJ 676070 is an antagonist of vasopressin V1A/V2 receptor.
CAS:
813426-25-4
Formula:
C19H23FN2O3
Molecular Weight:
346.4
Purity:
0.98
SMILES:
O=C1N(C)C(CC12CCN(CCCC(C3=CC=C(F)C=C3)=O)CC2)=O

References

1. Coltamai L, Bucher M, Maillard MP, Shukla U, Bohidar N, Haskell L, Bertelsen K, Fedgchin M, Vogt B, Burnier M. Vascular effects of RWJ-676070, a selective combined V1a/V2 vasopressin receptor antagonist. Clin Pharmacol Ther. 2009 Feb;85(2):145-8. doi: 10.1038/clpt.2008.217. PubMed PMID: 18987622. 2. Gunnet JW, Wines P, Xiang M, Rybczynski P, Andrade-Gordon P, de Garavilla L, Parry TJ, Cheung WM, Minor L, Demarest KT, Maryanoff BE, Damiano BP. Pharmacological characterization of RWJ-676070, a dual vasopressin V(1A)/V(2) receptor antagonist. Eur J Pharmacol. 2008 Aug 20;590(1-3):333-42. doi: 10.1016/j.ejphar.2008.06.010. PubMed PMID: 18599033. 3. Xiang MA, Rybczynski PJ, Patel M, Chen RH, McComsey DF, Zhang HC, Gunnet JW, Look R, Wang Y, Minor LK, Zhong HM, Villani FJ, Demarest KT, Damiano BP, Maryanoff BE. Next-generation spirobenzazepines: identification of RWJ-676070 as a balanced vasopressin V1a/V2 receptor antagonist for human clinical studies. Bioorg Med Chem Lett. 2007 Dec 1;17(23):6623-8. PubMed PMID: 17942308.